betaxolol has been researched along with Heart Failure in 8 studies
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " with NYHA II or III heart failure were double-blind randomized and uptitrated to either carvedilol 25 mg bid (n=131) or betaxolol 20 mg od (n=124)." | 9.12 | Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial). ( Chochola, J; Figulla, HR; Fridl, P; Kalmbach, C; Krzeminska-Pakula, M; Wrabec, K, 2006) |
| "The cardioprotective effects of betaxolol were studied in a rat model with heart failure induced by autoimmune myocarditis." | 7.72 | Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure. ( Aizawa, Y; Hasegawa, G; Inoue, M; Juan, W; Kodama, M; Ma, M; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Tachikawa, H; Takahashi, T; Tanabe, N; Wahed, MI; Watanabe, K; Yamaguchi, K; Yamamoto, T, 2003) |
| " with NYHA II or III heart failure were double-blind randomized and uptitrated to either carvedilol 25 mg bid (n=131) or betaxolol 20 mg od (n=124)." | 5.12 | Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial). ( Chochola, J; Figulla, HR; Fridl, P; Kalmbach, C; Krzeminska-Pakula, M; Wrabec, K, 2006) |
| "The cardioprotective effects of betaxolol were studied in a rat model with heart failure induced by autoimmune myocarditis." | 3.72 | Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure. ( Aizawa, Y; Hasegawa, G; Inoue, M; Juan, W; Kodama, M; Ma, M; Naito, M; Nakazawa, M; Narasimman, G; Saito, Y; Tachikawa, H; Takahashi, T; Tanabe, N; Wahed, MI; Watanabe, K; Yamaguchi, K; Yamamoto, T, 2003) |
| "Carvedilol was prescribed in 7 331 patients treated for HF (9." | 1.62 | Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic. ( Aiglova, R; Danek, J; Gloger, V; Lazarova, M; Pavlu, L; Precek, J; Schee, A; Skala, T; Taborsky, M; Vicha, M, 2021) |
| "Carvedilol was shown to be well tolerated and effective in elderly heart failure patients in the observational COLA II study." | 1.32 | Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy. ( Clark, AL; Cleland, JG; Coletta, AP; Freemantle, N, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Taborsky, M | 1 |
| Aiglova, R | 1 |
| Lazarova, M | 1 |
| Pavlu, L | 1 |
| Danek, J | 1 |
| Precek, J | 1 |
| Schee, A | 1 |
| Gloger, V | 1 |
| Vicha, M | 1 |
| Skala, T | 1 |
| Watanabe, K | 1 |
| Juan, W | 1 |
| Narasimman, G | 1 |
| Ma, M | 1 |
| Inoue, M | 1 |
| Saito, Y | 1 |
| Wahed, MI | 1 |
| Nakazawa, M | 1 |
| Hasegawa, G | 1 |
| Naito, M | 1 |
| Tachikawa, H | 1 |
| Tanabe, N | 1 |
| Kodama, M | 1 |
| Aizawa, Y | 1 |
| Yamamoto, T | 1 |
| Yamaguchi, K | 1 |
| Takahashi, T | 1 |
| Coletta, AP | 1 |
| Cleland, JG | 1 |
| Freemantle, N | 1 |
| Clark, AL | 1 |
| Figulla, HR | 2 |
| Krzeminska-Pakula, M | 1 |
| Wrabec, K | 1 |
| Chochola, J | 1 |
| Kalmbach, C | 1 |
| Fridl, P | 1 |
| Böhler, S | 1 |
| Saubadu, S | 1 |
| Scheldewaert, R | 1 |
| Waldock, A | 1 |
| Snape, J | 1 |
| Graham, CM | 1 |
| Herschman, Z | 1 |
| Kaufman, B | 1 |
| Ball, S | 1 |
3 trials available for betaxolol and Heart Failure
| Article | Year |
|---|---|
Betaxolol is equivalent to carvedilol in patients with heart failure NYHA II or III: result of a randomized multicenter trial (BETACAR Trial).
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Carbazoles; Carvedilol; Double-Blin | 2006 |
Betaxolol versus carvedilol in chronic heart failure (BETACAR study). Rationale and design.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Carbazoles; Carvedilol; Chronic Disease; Double | 1999 |
Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Betaxolol; Blood | 2000 |
5 other studies available for betaxolol and Heart Failure
| Article | Year |
|---|---|
Beta-blockers utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic.
Topics: Adrenergic beta-Antagonists; Betaxolol; Bisoprolol; Carbazoles; Carvedilol; Czech Republic; Heart Fa | 2021 |
Betaxolol improves the survival rate and changes natriuretic peptide expression in rats with heart failure.
Topics: Animals; Atrial Natriuretic Factor; Betaxolol; Gene Expression Regulation; Heart Failure; Male; Rats | 2003 |
Clinical trials update from the European Society of Cardiology Heart Failure meeting: SHAPE, BRING-UP 2 VAS, COLA II, FOSIDIAL, BETACAR, CASINO and meta-analysis of cardiac resynchronisation therapy.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carbazoles; Cardiac Pacing, Artificial; Carvedilol; Clinical | 2004 |
Complications arising from the use of ophthalmologic medications in an intensive care unit patient.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Bronchial Spasm; Female; Heart Failure; Humans; Intens | 1989 |
Congestive heart failure from betaxolol. Case report.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Betaxolol; Glaucoma, Open-Angle; Heart Failure | 1987 |